The UK Veterinary Medicines Directorate (VMD) and the Saudi Food and Drug Authority (SFDA) have signed a Memorandum of Understanding (MoU) to enhance bilateral cooperation on the regulation of veterinary medicines. This agreement is intended to safeguard public and animal health.
The MoU was signed in London during the “DIA–MHRA Global Summit: Global Collaboration for Safer and Smarter Health Innovation.” H.E. Dr. Hisham S. Aljadhey, Chief Executive Officer of the SFDA, and Ms. Abigail Seager, Chief Executive Officer of the VMD, signed the agreement.
Dr. Aljadhey stated that the partnership creates a framework for regulatory collaboration, technical capacity building, and information exchange. Ms. Seager highlighted that the agreement provides an opportunity for both countries to share scientific expertise and regulatory experience, and to learn from each other.
Under the MoU, the SFDA and VMD will exchange information on veterinary medicine regulation and availability, assessment reports, and regulatory requirements. They will also facilitate the exchange of experts and consultants, and support training initiatives to share knowledge and experience. Discussions will also cover regulatory policies, laboratory testing standards, pre- and post-marketing controls, market compliance, manufacturer regulation, and efforts to address antimicrobial resistance (AMR).